World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
12599
World Ranking
15488
National Ranking
6465

David W. Fry publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David W. Fry sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 117 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

David W. Fry D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David W. Fry sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

David W. Fry is affiliated with Pfizer in the United States. Their research spans several fields within medicine, with a focus on immunology and microbiology. The subfields in which they have contributed include oncology, immunology, genetics, and pulmonary and respiratory medicine.

Their work covers topics that intersect cancer immunotherapy and biomarker discovery, phagocytosis and immune regulation, immune cell functions and interactions, as well as research on HER2/EGFR in cancer and chronic lymphocytic leukemia. Lung cancer treatments and associated mutations are also among the key subjects addressed in their research portfolio.

David W. Fry has published in notable venues such as Gastroenterology and UNC Libraries. Their recent papers include:

  • Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer, 2020, Gastroenterology
  • Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy, 2020, UNC Libraries

The frequent co-authors collaborating with David W. Fry are Ying Ma, Jun Li, Huamin Wang, Yulun Chiu, and Charles V. Kingsley.

Best Publications

  • A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

    David W. Fry;Alan J. Kraker;Amy McMichael;Linda A. Ambroso

  • Irreversible inhibitors of tyrosine kinases

    Alexander James Bridges;William Alexander Denny;Ellen Myra Dobrusin;Annette Marian Doherty

  • Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2.

    James D. Owen;Paul J. Ruest;David W. Fry;Steven K. Hanks

  • Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

    David W. Fry;Alexander J. Bridges;William A. Denny;Annette Doherty

  • Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

    Alexander J. Bridges;Hairong Zhou;Donna R. Cody;Gordon W. Rewcastle

  • Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

    Alexander James Bridges;William Alexander Denny;David Fry;Alan Kraker

  • Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.

    Gordon W. Rewcastle;William A. Denny;Alexander J. Bridges;Hairong Zhou

  • Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

    Andrea J. Gonzales;Kenneth E. Hook;Irene W. Althaus;Paul A. Ellis

  • Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.

    J. B. Smaill;B. D. Palmer;G. W. Rewcastle;W. A. Denny

  • Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation

    Diane Harris Boschelli;Ellen Myra Dobrusin;Annette Marian Doherty;Ali Fattaey

  • Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy

    Ami Citri;Iris Alroy;Sara Lavi;Chanan Rubin

  • Structure−Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors

    James M. Hamby;Cleo J. C. Connolly;Mel C. Schroeder;R. Thomas Winters

  • Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.

    Scott N. Vanderwel;Patricia J. Harvey;Dennis J. Mcnamara;Joseph T. Repine

  • Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor

    Gordon W. Rewcastle;Brian D. Palmer;Alexander J. Bridges;H. D. Hollis Showalter

  • Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway.

    Jess M. Cunnick;Jay F. Dorsey;Todd Standley;James Turkson

  • Tyrosine kinase inhibitors. 7. 7-Amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.

    Andrew M. Thompson;Alexander J. Bridges;David W. Fry;Alan J. Kraker

  • Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors.

    David W. Fry

  • Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.

    Gordon W. Rewcastle;Brian D. Palmer;Andrew M. Thompson;Alexander J. Bridges

  • Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.

    H. D. Hollis Showalter;Alexander J. Bridges;Hairong Zhou;Anthony D. Sercel

  • Inhibitors of tyrosine kinase.

    Wayne D. Klohs;David W. Fry;Alan J. Kraker

Frequent Co-Authors

William A. Denny
William A. Denny University of Auckland
Brian D. Palmer
Brian D. Palmer University of Auckland
Richard J. Cote
Richard J. Cote Washington University in St. Louis
James T. Elder
James T. Elder University of Michigan–Ann Arbor
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Leonard M. Neckers
Leonard M. Neckers National Institutes of Health
Susan E. Bates
Susan E. Bates Columbia University
Zena Werb
Zena Werb University of California, San Francisco
Edison T. Liu
Edison T. Liu The Jackson Laboratory
Timothy G. Myers
Timothy G. Myers National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are passionate about Biology or Biochemistry, there are multiple flexible online programs to help you advance your career in related fields. For those considering healthcare, several online options offer both entry-level and specialized credentials.

Nurses looking to quickly expand their expertise in mental health may consider a 1 year pmhnp program, which is designed to prepare professionals for the psychiatric mental health nurse practitioner role in just one year. Similarly, current advanced practice nurses can pursue post masters fnp programs that provide flexibility to become a Family Nurse Practitioner online.

If your interest lies in food science and nutrition, you can explore some of the best online registered dietitian programs, which offer affordable and accredited training required to become a registered dietitian.

For those already working as registered nurses, earning a bachelor’s degree through an rn to bsn online program can enhance your qualifications and open up leadership opportunities.

With these diverse online pathways, students with a background in biology or biochemistry can build meaningful careers in healthcare, research, or nutrition from anywhere in the USA.

Best Scientists Citing David W. Fry

Recently Published Articles